144 related articles for article (PubMed ID: 3532295)
1. Effects of 800 mg cimetidine once daily on gastric acid secretion.
Dammann HG; Walter TA; Mueller P; Simon B
Scand J Gastroenterol Suppl; 1986; 121():25-9. PubMed ID: 3532295
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal gastric acid secretion: its importance in the pathophysiology and rational therapy of duodenal ulcer.
De Gara CJ; Gledhill T; Hunt RH
Scand J Gastroenterol Suppl; 1986; 121():17-24. PubMed ID: 3532294
[TBL] [Abstract][Full Text] [Related]
3. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
4. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
5. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
de Gara CJ; Burget DW; Silletti C; Hunt RH
Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
[TBL] [Abstract][Full Text] [Related]
6. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
[TBL] [Abstract][Full Text] [Related]
8. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
[TBL] [Abstract][Full Text] [Related]
9. Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.
Deakin M; Glenny HP; Ramage JK; Mills JG; Burland WL; Williams JG
Gut; 1987 May; 28(5):566-72. PubMed ID: 3596338
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
11. The evolution of anti-ulcer therapy with cimetidine. Is a single large nocturnal dose of cimetidine the right therapy for duodenal ulcer?
Barbara L; Corinaldesi B; Stanghellini V; Paternicò A; Fabbri L; Sacco T
Scand J Gastroenterol Suppl; 1986; 121():1-5. PubMed ID: 3532292
[TBL] [Abstract][Full Text] [Related]
12. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Bianchi Porro G
Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
[TBL] [Abstract][Full Text] [Related]
13. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
15. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
Khasawneh SM; Affarah HB
Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
[TBL] [Abstract][Full Text] [Related]
16. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
18. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
19. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy.
Feldman M; Richardson CT
Gastroenterology; 1986 Mar; 90(3):540-4. PubMed ID: 3943686
[TBL] [Abstract][Full Text] [Related]
20. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]